Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4 | Nature
Regulated cell death (RCD) in cancer: key pathways and targeted therapies | Signal Transduction and Targeted Therapy
Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells | British Journal of Cancer
Potential therapeutic targets for disulfiram in a cancer cell.... | Download Scientific Diagram
Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram | Cell Communication and Signaling | Full Text
The combination of disulfiram and copper for cancer treatment - ScienceDirect
Disulfiram and BKM120 in Combination with Chemotherapy Impede Tumor Progression and Delay Tumor Recurrence in Tumor Initiating Cell-Rich TNBC | Scientific Reports
Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies | British Journal of Cancer
Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties | Nature Communications
Double trouble: A drug for alcoholism can also treat cancer by targeting macrophages | Tokyo University of Science
Frontiers | Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents
Disulfiram-loaded metal organic framework for precision cancer treatment via ultrasensitive tumor microenvironment-responsive copper chelation and radical generation - ScienceDirect
Intestinal microbiota regulates anti‐tumor effect of disulfiram combined with Cu2+ in a mice model - Hu - 2020 - Cancer Medicine - Wiley Online Library
Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties | Nature Communications
Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells | British Journal of Cancer
Disulfiram's anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase | Oncogene
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4 | Nature
Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells | British Journal of Cancer
Diethyldithiocarbamate-copper complex (CuET) inhibits colorectal cancer progression via miR-16-5p and 15b-5p/ALDH1A3/PKM2 axis-mediated aerobic glycolysis pathway | Oncogenesis
Targeting EMT in Cancer with Repurposed Metabolic Inhibitors: Trends in Cancer
Cancers | Free Full-Text | Disulfiram as a Therapeutic Agent for Metastatic Malignant Melanoma—Old Myth or New Logos?
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4 | Nature
Disulfiram, an aldehyde dehydrogenase inhibitor, works as a potent drug against sepsis and cancer via NETosis, pyroptosis, apoptosis, ferroptosis, and cuproptosis | Blood Science
Disulfiram-loaded lactoferrin nanoparticles for treating inflammatory diseases | Acta Pharmacologica Sinica
Disulfiram's anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase | Oncogene
Disulfiram and copper combination therapy targets NPL4, cancer stem cells and extends survival in a medulloblastoma model | PLOS ONE
Disulfiram and copper combination therapy targets NPL4, cancer stem cells and extends survival in a medulloblastoma model | PLOS ONE
Disulfiram: a novel repurposed drug for cancer therapy | SpringerLink
